Skip to main content
Fig. 6 | Clinical Proteomics

Fig. 6

From: LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy

Fig. 6

The diagnostic efficacy of biomarkers in IgAN. A ROC analysis of the combined model was performed to evaluate the diagnostic performance in the training set. B ROC analysis of the combined model was performed to assess the diagnostic performance in the testing set. C ROC analysis of the combined model was performed to evaluate the diagnostic performance in the entire collection. D ROC analysis of the four biomarkers was performed to evaluate the diagnostic performance in the entire collection, respectively

Back to article page

Clinical Proteomics

ISSN: 1559-0275